Abstract
Hearing loss affects nearly 1.6 billion people and is the third-leading cause of disability worldwide. Chronic kidney disease (CKD) is also a common condition that is associated with adverse clinical outcomes and high health-care costs. From a developmental perspective, the structures responsible for hearing have a common morphogenetic origin with the kidney, and genetic abnormalities that cause familial forms of hearing loss can also lead to kidney disease. On a cellular level, normal kidney and cochlea function both depend on cilial activities at the apical surface, and kidney tubular cells and sensory epithelial cells of the inner ear use similar transport mechanisms to modify luminal fluid. The two organs also share the same collagen IV basement membrane network. Thus, strong developmental and physiological links exist between hearing and kidney function. These theoretical considerations are supported by epidemiological data demonstrating that CKD is associated with a graded and independent excess risk of sensorineural hearing loss. In addition to developmental and physiological links between kidney and cochlear function, hearing loss in patients with CKD may be driven by specific medications or treatments, including haemodialysis. The associations between these two common conditions are not commonly appreciated, yet have important implications for research and clinical practice.
Key points
-
Chronic kidney disease (CKD) and hearing loss are common conditions that individually cause tremendous morbidity but which often coexist.
-
The kidneys and the hearing organs share a common morphogenetic origin and rely on similar biological structures (for example, cilia) and processes (for example, specialized cellular transport mechanisms) to function.
-
Genetic abnormalities that cause CKD can also cause hearing loss, and vice versa.
-
A strong, graded and independent relationship exists between kidney function and the risk of hearing loss; the highest risk is observed in patients on haemodialysis, but kidney transplant recipients and people with mild CKD are also at increased risk.
-
Infants, children and possibly adults with malformation or dysfunction of their hearing organs should be evaluated for the presence of malformation or dysfunction of their kidneys, and vice versa.
-
Additional funding is needed to support basic, clinical and health services research that explores the intersection between these two relatively neglected conditions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. Deafness and hearing loss. who.int, https: //www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss (accessed 1 March 2023).
National Institute on Deafness and Other Communication Disorders, National Institutes of Health. Quick statistics about hearing. nidcd.nih.gov, https: //www.nidcd.nih.gov/health/statistics/quick-statistics-hearing (accessed 1 March 2023).
Mick, P. T. et al. The prevalence of hearing, vision, and dual sensory loss in older Canadians: an analysis of data from the Canadian Longitudinal Study on Aging. Can. J. Aging 40, 1–22 (2021).
World Health Organization. Integrated people-centred ear and hearing care: policy brief. apps.who.int, https://apps.who.int/iris/handle/10665/339957 (accessed 1 March 2023).
Anderson, D. L. & Noble, W. Couples’ attributions about behaviours modulated by hearing impairment: links with relationship satisfaction. Int. J. Audiol. 44, 197–205 (2005).
Hétu, R., Jones, L. & Getty, L. The impact of acquired hearing impairment on intimate relationships: implications for rehabilitation. Audiology 32, 363–381 (1993).
National Research Council (US) Committee on Disability Determination for Individuals with Hearing Impairments. Hearing Loss: Determining Eligibility for Social Security Benefits. (National Academies Press (US), 2004).
Tordrup, D. et al. Global return on investment and cost-effectiveness of WHO’s HEAR interventions for hearing loss: a modelling study. Lancet Glob. Health 10, e52–e62 (2022).
Monzani, D., Galeazzi, G. M., Genovese, E., Marrara, A. & Martini, A. Psychological profile and social behaviour of working adults with mild or moderate hearing loss. Acta Otorhinolaryngol. Ital. 28, 61–66 (2008).
Lin, F. R. & Albert, M. Hearing loss and dementia — who is listening? Aging Ment. Health 18, 671–673 (2014).
Dalton, D. S. et al. The impact of hearing loss on quality of life in older adults. Gerontologist 43, 661–668 (2003).
Hixon, B., Chan, S., Adkins, M., Shinn, J. B. & Bush, M. L. Timing and impact of hearing healthcare in adult cochlear implant recipients: a rural-urban comparison. Otol. Neurotol. 37, 1320–1324 (2016).
Nieman, C. L., Marrone, N., Szanton, S. L., Thorpe, R. J. Jr & Lin, F. R. Racial/ethnic and socioeconomic disparities in hearing health care among older Americans. J. Aging Health 28, 68–94 (2016).
Schuh, M. R. & Bush, M. L. Evaluating equity through the social determinants of hearing health. Ear Hear. 43, 15s–22s (2022).
World Health Organization. World Report on Hearing. apps.who.int, https: //apps.who.int/iris/handle/10665/339913 (accessed 1 March 2023).
Agrawal, Y., Platz, E. A. & Niparko, J. K. Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999–2004. Arch. Intern. Med. 168, 1522–1530 (2008).
Ramage-Morin, P. L., Banks, R., Pineault, D. & Atrach, M. Unperceived hearing loss among Canadians aged 40 to 79. Health Rep. 30, 11–20 (2019).
Baguant, A., Cole, A., Vilotitch, A., Quatre, R. & Schmerber, S. Difference in cochlear length between male and female patients. Cochlear Implant. 23, 326–331 (2022).
Shuster, B. Z., Depireux, D. A., Mong, J. A. & Hertzano, R. Sex differences in hearing: probing the role of estrogen signaling. J. Acoust. Soc. Am. 145, 3656 (2019).
Tonelli, M. et al. Associations between hearing loss and clinical outcomes: population-based cohort study. EClinicalMedicine 61, 102068 (2023).
Newsted, D. et al. Approach to hearing loss. Can. Fam. Physician 66, 803–809 (2020).
Snoeckx, R. L. et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am. J. Hum. Genet. 77, 945–957 (2005).
Anthwal, N. & Thompson, H. The development of the mammalian outer and middle ear. J. Anat. 228, 217–232 (2016).
Luers, J. C. & Huttenbrink, K. B. Surgical anatomy and pathology of the middle ear. J. Anat. 228, 338–353 (2016).
Hartwein, J. H. & Rauchfuss, A. The development of the ossicular ligaments in the human middle ear. Arch. Otorhinolaryngol. 244, 23–25 (1987).
McCarroll, M. N. et al. Graded levels of Pax2a and Pax8 regulate cell differentiation during sensory placode formation. Development 139, 2740–2750 (2012).
Sai, X. & Ladher, R. K. FGF signaling regulates cytoskeletal remodeling during epithelial morphogenesis. Curr. Biol. 18, 976–981 (2008).
Alvarez, Y. et al. Requirements for FGF3 and FGF10 during inner ear formation. Development 130, 6329–6338 (2003).
Pauley, S. et al. Expression and function of FGF10 in mammalian inner ear development. Dev. Dyn. 227, 203–215 (2003).
Riley, B. B. & Phillips, B. T. Ringing in the new ear: resolution of cell interactions in otic development. Dev. Biol. 261, 289–312 (2003).
Brigande, J. V., Kiernan, A. E., Gao, X., Iten, L. E. & Fekete, D. M. Molecular genetics of pattern formation in the inner ear: do compartment boundaries play a role? Proc. Natl Acad. Sci. USA 97, 11700–11706 (2000).
Chatterjee, S., Kraus, P. & Lufkin, T. A symphony of inner ear developmental control genes. BMC Genet. 11, 68 (2010).
Bok, J. et al. Transient retinoic acid signaling confers anterior-posterior polarity to the inner ear. Proc. Natl Acad. Sci. USA 108, 161–166 (2011).
Chang, W., Nunes, F. D., De Jesus-Escobar, J. M., Harland, R. & Wu, D. K. Ectopic noggin blocks sensory and nonsensory organ morphogenesis in the chicken inner ear. Dev. Biol. 216, 369–381 (1999).
Riccomagno, M. M., Takada, S. & Epstein, D. J. Wnt-dependent regulation of inner ear morphogenesis is balanced by the opposing and supporting roles of Shh. Genes. Dev. 19, 1612–1623 (2005).
Zheng, W. et al. The role of Six1 in mammalian auditory system development. Development 130, 3989–4000 (2003).
Ozaki, H. et al. Six1 controls patterning of the mouse otic vesicle. Development 131, 551–562 (2004).
Khan, S. & Chang, R. Anatomy of the vestibular system: a review. NeuroRehabilitation 32, 437–443 (2013).
Driver, E. C. & Kelley, M. W. Development of the cochlea. Development 147, dev162263 (2020).
Moser, T. & Starr, A. Auditory neuropathy — neural and synaptic mechanisms. Nat. Rev. Neurol. 12, 135–149 (2016).
Raphael, R. M. Outer hair cell electromechanics as a problem in soft matter physics: prestin, the membrane and the cytoskeleton. Hear. Res. 423, 108426 (2022).
Zhou, W., Jabeen, T., Sabha, S., Becker, J. & Nam, J. H. Deiters cells act as mechanical equalizers for outer hair cells. J. Neurosci. 42, 8361–8372 (2022).
Maier, E. C. & Whitfield, T. T. RA and FGF signalling are required in the zebrafish otic vesicle to pattern and maintain ventral otic identities. PLoS Genet. 10, e1004858 (2014).
Ahmed, M. et al. Eya1-Six1 interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 expression in cooperation with Sox2. Dev. Cell 22, 377–390 (2012).
Kamaid, A., Neves, J. & Giraldez, F. Id gene regulation and function in the prosensory domains of the chicken inner ear: a link between Bmp signaling and Atoh1. J. Neurosci. 30, 11426–11434 (2010).
Jeon, S. J., Fujioka, M., Kim, S. C. & Edge, A. S. Notch signaling alters sensory or neuronal cell fate specification of inner ear stem cells. J. Neurosci. 31, 8351–8358 (2011).
Tateya, T. et al. Hedgehog signaling regulates prosensory cell properties during the basal-to-apical wave of hair cell differentiation in the mammalian cochlea. Development 140, 3848–3857 (2013).
Mugford, J. W., Sipila, P., McMahon, J. A. & McMahon, A. P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev. Biol. 324, 88–98 (2008).
James, R. G., Kamei, C. N., Wang, Q., Jiang, R. & Schultheiss, T. M. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 133, 2995–3004 (2006).
Gong, K. Q., Yallowitz, A. R., Sun, H., Dressler, G. R. & Wellik, D. M. A Hox-Eya-Pax complex regulates early kidney developmental gene expression. Mol. Cell Biol. 27, 7661–7668 (2007).
Xu, P. X. et al. Six1 is required for the early organogenesis of mammalian kidney. Development 130, 3085–3094 (2003).
Chai, L. et al. Transcriptional activation of the SALL1 by the human SIX1 homeodomain during kidney development. J. Biol. Chem. 281, 18918–18926 (2006).
Moreau, E., Vilar, J., Lelievre-Pegorier, M., Merlet-Benichou, C. & Gilbert, T. Regulation of c-ret expression by retinoic acid in rat metanephros: implication in nephron mass control. Am. J. Physiol. 275, F938–F945 (1998).
Tang, M. J., Worley, D., Sanicola, M. & Dressler, G. R. The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells. J. Cell Biol. 142, 1337–1345 (1998).
Tang, M. J., Cai, Y., Tsai, S. J., Wang, Y. K. & Dressler, G. R. Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev. Biol. 243, 128–136 (2002).
Basson, M. A. et al. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev. Cell 8, 229–239 (2005).
Grieshammer, U. et al. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev. Cell 6, 709–717 (2004).
Majumdar, A., Vainio, S., Kispert, A., McMahon, J. & McMahon, A. P. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 130, 3175–3185 (2003).
Bates, C. M. Role of fibroblast growth factor receptor signaling in kidney development. Pediatr. Nephrol. 22, 343–349 (2007).
Iglesias, D. M. et al. Canonical WNT signaling during kidney development. Am. J. Physiol. Renal Physiol. 293, F494–F500 (2007).
Michos, O. et al. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131, 3401–3410 (2004).
Piscione, T. D., Phan, T. & Rosenblum, N. D. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am. J. Physiol. Renal Physiol. 280, F19–F33 (2001).
Cain, J. E. et al. GLI3 repressor controls nephron number via regulation of Wnt11 and Ret in ureteric tip cells. PLoS ONE 4, e7313 (2009).
O’Brien, L. L. & McMahon, A. P. Induction and patterning of the metanephric nephron. Semin. Cell Dev. Biol. 36, 31–38 (2014).
Kobayashi, A. et al. Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Rep. 3, 650–662 (2014).
Boyle, S. et al. Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev. Biol. 313, 234–245 (2008).
Kobayashi, A. et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3, 169–181 (2008).
Ramalingam, H. et al. Disparate levels of beta-catenin activity determine nephron progenitor cell fate. Dev. Biol. 440, 13–21 (2018).
Stark, K., Vainio, S., Vassileva, G. & McMahon, A. P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372, 679–683 (1994).
Carroll, T. J., Park, J. S., Hayashi, S., Majumdar, A. & McMahon, A. P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell 9, 283–292 (2005).
Torban, E. et al. PAX2 activates WNT4 expression during mammalian kidney development. J. Biol. Chem. 281, 12705–12712 (2006).
Georgas, K. et al. Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment. Dev. Biol. 332, 273–286 (2009).
Nakai, S. et al. Crucial roles of Brn1 in distal tubule formation and function in mouse kidney. Development 130, 4751–4759 (2003).
Cheng, H. T. et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134, 801–811 (2007).
Bertram, J. F., Douglas-Denton, R. N., Diouf, B., Hughson, M. D. & Hoy, W. E. Human nephron number: implications for health and disease. Pediatr. Nephrol. 26, 1529–1533 (2011).
Haraldsson, B., Nystrom, J. & Deen, W. M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88, 451–487 (2008).
Brown, D., Bouley, R., Paunescu, T. G., Breton, S. & Lu, H. A. New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells. Am. J. Physiol. Cell Physiol. 302, C1421–C1433 (2012).
Delling, M., DeCaen, P. G., Doerner, J. F., Febvay, S. & Clapham, D. E. Primary cilia are specialized calcium signalling organelles. Nature 504, 311–314 (2013).
Marshall, W. F. & Nonaka, S. Cilia: tuning in to the cell’s antenna. Curr. Biol. 16, R604–R614 (2006).
Webber, W. A. & Lee, J. Fine structure of mammalian renal cilia. Anat. Rec. 182, 339–343 (1975).
Eshraghi, A. A. et al. Genotype-phenotype correlation for predicting cochlear implant outcome: current challenges and opportunities. Front. Genet. 11, 678 (2020).
Bower, M. et al. Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum. Mutat. 33, 457–466 (2012).
Schimmenti, L. A. Renal coloboma syndrome. Eur. J. Hum. Genet. 19, 1207–1212 (2011).
Giovanella, S. et al. PAX2/renal coloboma syndrome expresses extreme intrafamilial phenotypic variability. Nephron 147, 120–126 (2023).
Devriendt, K. et al. Missense mutation and hexanucleotide duplication in the PAX2 gene in two unrelated families with renal-coloboma syndrome (MIM 120330). Hum. Genet. 103, 149–153 (1998).
Torres, M., Gomez-Pardo, E., Dressler, G. R. & Gruss, P. Pax-2 controls multiple steps of urogenital development. Development 121, 4057–4065 (1995).
Porteous, S. et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax21Neu +/− mutant mice. Hum. Mol. Genet. 9, 1–11 (2000).
Torres, M., Gomez-Pardo, E. & Gruss, P. Pax2 contributes to inner ear patterning and optic nerve trajectory. Development 122, 3381–3391 (1996).
Kochhar, A., Fischer, S. M., Kimberling, W. J. & Smith, R. J. Branchio-oto-renal syndrome. Am. J. Med. Genet. A 143A, 1671–1678 (2007).
Chen, A. et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am. J. Med. Genet. 58, 365–370 (1995).
Gimsing, S. & Dyrmose, J. Branchio-oto-renal dysplasia in three families. Ann. Otol. Rhinol. Laryngol. 95, 421–426 (1986).
Konig, R., Fuchs, S. & Dukiet, C. Branchio-oto-renal (BOR) syndrome: variable expressivity in a five-generation pedigree. Eur. J. Pediatr. 153, 446–450 (1994).
Kemperman, M. H. et al. Evidence of progression and fluctuation of hearing impairment in branchio-oto-renal syndrome. Int. J. Audiol. 43, 523–532 (2004).
Tian, L., West, N. & Caye-Thomasen, P. Cochlear implantation in Branchiootorenal syndrome — case report and review of the literature. Cochlear Implant. Int. 23, 52–57 (2022).
Weber, K. M. & Kousseff, B. G. ‘New’ manifestations of BOR syndrome. Clin. Genet. 56, 306–312 (1999).
Chang, E. H. et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum. Mutat. 23, 582–589 (2004).
Kochhar, A. et al. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum. Mutat. 29, 565 (2008).
Hoskins, B. E. et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am. J. Hum. Genet. 80, 800–804 (2007).
Cacciatori, E. et al. From clinical to molecular diagnosis: relevance of diagnostic strategy in two cases of branchio-oto-renal syndrome — case report. Ital. J. Pediatr. 48, 177 (2022).
Buller, C., Xu, X., Marquis, V., Schwanke, R. & Xu, P. X. Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. Hum. Mol. Genet. 10, 2775–2781 (2001).
Mehdizadeh, T., Majumdar, H. D., Ahsan, S., Tavares, A. L. P. & Moody, S. A. Mutations in SIX1 associated with branchio-oto-renal syndrome (BOR) differentially affect otic expression of putative target genes. J. Dev. Biol. 9, 25 (2021).
Musharraf, A. et al. BOR-syndrome-associated Eya1 mutations lead to enhanced proteasomal degradation of Eya1 protein. PLoS ONE 9, e87407 (2014).
Cai, T. & Groves, A. K. The role of atonal factors in mechanosensory cell specification and function. Mol. Neurobiol. 52, 1315–1329 (2015).
Riddiford, N. & Schlosser, G. Dissecting the pre-placodal transcriptome to reveal presumptive direct targets of Six1 and Eya1 in cranial placodes. eLife 5, e17666 (2016).
Sajithlal, G., Zou, D., Silvius, D. & Xu, P. X. Eya 1 acts as a critical regulator for specifying the metanephric mesenchyme. Dev. Biol. 284, 323–336 (2005).
Kohlhase, J. et al. Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am. J. Hum. Genet. 64, 435–445 (2015).
Doray, B., Langer, B. & Stoll, C. Two cases of Townes-Brocks syndrome. Genet. Couns. 10, 359–367 (1990).
Miller, E. M., Hopkin, R., Bao, L. & Ware, S. M. Implications for genotype-phenotype predictions in Townes-Brocks syndrome: case report of a novel SALL1 deletion and review of the literature. Am. J. Med. Genet. A 158A, 533–540 (2012).
Beaudoux, O. et al. Adult diagnosis of Townes-Brocks syndrome with renal failure: two related cases and review of literature. Am. J. Med. Genet. A 185, 937–944 (2021).
Bozal-Basterra, L. et al. Truncated SALL1 impedes primary cilia function in Townes-Brocks syndrome. Am. J. Hum. Genet. 102, 249–265 (2018).
Liu, Y. & Zhi, X. Advances in genetic diagnosis of Kallmann syndrome and genetic interruption. Reprod. Sci. 29, 1697–1709 (2022).
Costa-Barbosa, F. A. et al. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J. Clin. Endocrinol. Metab. 98, E943–E953 (2013).
Duke, V. M. et al. KAL, a gene mutated in Kallmann’s syndrome, is expressed in the first trimester of human development. Mol. Cell Endocrinol. 110, 73–79 (1995).
Hardelin, J. P. et al. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev. Dyn. 215, 26–44 (1999).
Ernest, S., Guadagnini, S., Prevost, M. C. & Soussi-Yanicostas, N. Localization of anosmin-1a and anosmin-1b in the inner ear and neuromasts of zebrafish. Gene Expr. Patterns 7, 274–281 (2007).
Raju, R., Jian, B., Hooks, J. J. & Nagineni, C. N. Transforming growth factor-beta regulates the expression of anosmin (KAL-1) in human retinal pigment epithelial cells. Cytokine 61, 724–727 (2013).
Blake, K. D. & Prasad, C. CHARGE syndrome. Orphanet J. Rare Dis. 1, 34 (2006).
Verloes, A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am. J. Med. Genet. A 133A, 306–308 (2005).
Jiramongkolchai, P., Kumar, M. S., Chinnadurai, S., Wootten, C. T. & Goudy, S. L. Prevalence of hearing loss in children with 22q11.2 deletion syndrome. Int. J. Pediatr. Otorhinolaryngol. 87, 130–133 (2016).
Lopez-Rivera, E. et al. Genetic drivers of kidney defects in the DiGeorge syndrome. N. Engl. J. Med. 376, 742–754 (2017).
Van Esch, H. & Devriendt, K. Transcription factor GATA3 and the human HDR syndrome. Cell Mol. Life Sci. 58, 1296–1300 (2001).
Johnston, J. J. et al. Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum. Mutat. 31, 1142–1154 (2010).
McClelland, K., Li, W. & Rosenblum, N. D. Pallister-Hall syndrome, GLI3, and kidney malformation. Am. J. Med. Genet. C. Semin. Med. Genet. 190, 264–278 (2022).
Driver, E. C. et al. Hedgehog signaling regulates sensory cell formation and auditory function in mice and humans. J. Neurosci. 28, 7350–7358 (2008).
Avula, S., Alam, N. & Roberts, E. Cochlear abnormality in a case of Pallister-Hall syndrome. Pediatr. Radiol. 42, 1502–1505 (2012).
D’Cruz, R., Stronks, K., Rowan, C. J. & Rosenblum, N. D. Lineage-specific roles of hedgehog-GLI signaling during mammalian kidney development. Pediatr. Nephrol. 35, 725–731 (2020).
Moon, K. H. et al. Dysregulation of sonic hedgehog signaling causes hearing loss in ciliopathy mouse models. eLife 9, e56551 (2020).
Wolf, M. T. & Hildebrandt, F. Nephronophthisis. Pediatr. Nephrol. 26, 181–194 (2011).
Forsythe, E. & Beales, P. L. Bardet-Biedl syndrome. Eur. J. Hum. Genet. 21, 8–13 (2013).
Deveault, C. et al. BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum. Mutat. 32, 610–619 (2011).
Forsythe, E. et al. Risk factors for severe renal disease in Bardet-Biedl syndrome. J. Am. Soc. Nephrol. 28, 963–970 (2017).
Beales, P. L., Elcioglu, N., Woolf, A. S., Parker, D. & Flinter, F. A. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J. Med. Genet. 36, 437–446 (1999).
Jin, H. et al. The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to cilia. Cell 141, 1208–1219 (2010).
Oeffner, F. et al. Novel interaction partners of Bardet-Biedl syndrome proteins. Cell Motil. Cytoskeleton 65, 143–155 (2008).
Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N. Engl. J. Med. 348, 2543–2556 (2003).
Gibson, J. et al. Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J. Am. Soc. Nephrol. 32, 2273–2290 (2021).
Boeckhaus, J., Strenzke, N., Storz, C. & Gross, O., On Behalf Of The Gpn Study G, Early Pro-Tect Alport I. Characterization of sensorineural hearing loss in children with Alport syndrome. Life 10, 360 (2020).
Goyal, S. et al. Cochlear implantation in patients with renal dysfunction. journal article. J. Hearing Sci. 6, 25–35 (2016).
Mohammad, M. et al. A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations. Pediatr. Nephrol. 29, 481–485 (2014).
Kleppel, M. M., Santi, P. A., Cameron, J. D., Wieslander, J. & Michael, A. F. Human tissue distribution of novel basement membrane collagen. Am. J. Pathol. 134, 813–825 (1989).
Savige, J., Huang, M., Croos Dabrera, M. S., Shukla, K. & Gibson, J. Genotype-phenotype correlations for pathogenic COL4A3-COL4A5 variants in X-linked, autosomal recessive, and autosomal dominant Alport syndrome. Front. Med. 9, 865034 (2022).
Jais, J. P. et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J. Am. Soc. Nephrol. 11, 649–657 (2000).
Jais, J. P. et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J. Am. Soc. Nephrol. 14, 2603–2610 (2003).
Bittencourt, A. G. et al. Post-lingual deafness: benefits of cochlear implants vs. conventional hearing aids. Braz. J. Otorhinolaryngol. 78, 124–127 (2012).
Yassin, A., Badry, A. & Fatt-Hi, A. The relationship between electrolyte balance and cochlear disturbances in cases of renal failure. J. Laryngol. Otol. 84, 429–435 (1970).
Moon, I. S., Bang, M. Y., Shim, D. B., Shin, S. H. & Choi, J. Y. Severe to profound hearing loss in patients with progressed Alport’s syndrome. Acta Otolaryngol. 129, 982–987 (2009).
Yamamura, T. et al. Natural history and genotype-phenotype correlation in female X-linked Alport syndrome. Kidney Int. Rep. 2, 850–855 (2017).
Lee, J. M. et al. Features of autosomal recessive Alport syndrome: a systematic review. J. Clin. Med. 8, 170 (2019).
Nozu, K. et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin. Exp. Nephrol. 23, 158–168 (2019).
Cosgrove, D. et al. Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear. Res. 121, 84–98 (1998).
Kalluri, R., Gattone, V. H. II & Hudson, B. G. Identification and localization of type IV collagen chains in the inner ear cochlea. Connect. Tissue Res. 37, 143–150 (1998).
Harvey, S. J. et al. The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am. J. Pathol. 159, 1097–1104 (2001).
Zehnder, A. F. et al. Distribution of type IV collagen in the cochlea in Alport syndrome. Arch. Otolaryngol. Head. Neck Surg. 131, 1007–1013 (2019).
Barozzi, S. et al. Vestibular and audiological findings in the Alport syndrome. Am. J. Med. Genet. A 182, 2345–2358 (2020).
Kalluri, R., Shield, C. F., Todd, P., Hudson, B. G. & Neilson, E. G. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest. 99, 2470–2478 (1997).
Shen, Z., Liang, F., Hazen-Martin, D. J. & Schulte, B. A. BK channels mediate the voltage-dependent outward current in type I spiral ligament fibrocytes. Hear. Res. 187, 35–43 (2004).
Kantarci, S. et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat. Genet. 39, 957–959 (2007).
Christensen, E. I. & Birn, H. Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell Biol. 3, 256–266 (2002).
Goto, S., Hosojima, M., Kabasawa, H. & Saito, A. The endocytosis receptor megalin: from bench to bedside. Int. J. Biochem. Cell Biol. 157, 106393 (2023).
Hori, Y. et al. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J. Am. Soc. Nephrol. 28, 1783–1791 (2017).
Pober, B. R., Longoni, M. & Noonan, K. M. A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis. Birth Defects Res. A Clin. Mol. Teratol. 85, 76–81 (2009).
Storm, T. et al. Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration. Nephrol. Dial. Transpl. 28, 585–591 (2013).
Charlton, J. R. et al. Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease. Am. J. Physiol. Renal Physiol. 319, F988–F999 (2020).
Alyousef, M. Y. et al. Performance of children with Donnai-Barrow syndrome after cochlear implantation: a case report. Cureus 14, e21063 (2022).
Bruce, I. A., Broomfield, S. J., Henderson, L., Green, K. M. & Ramsden, R. T. Cochlear implantation in Donnai-Barrow syndrome. Cochlear Implant. Int. 12, 60–63 (2011).
Konig, O. et al. Estrogen and the inner ear: megalin knockout mice suffer progressive hearing loss. FASEB J. 22, 410–417 (2008).
Shuster, B. et al. Estradiol protects against noise-induced hearing loss and modulates auditory physiology in female mice. Int. J. Mol. Sci. 22, 12208 (2021).
Kim, J. & Ricci, A. J. In vivo real-time imaging reveals megalin as the aminoglycoside gentamicin transporter into cochlea whose inhibition is otoprotective. Proc. Natl Acad. Sci. USA 119, e2117946119 (2022).
Ransome, J., Bllantyne, J. C., Shaldon, S., Bosher, S. K. & Hallpike, C. S. Perceptive deafness in subjects with renal failure treated with haemodialysis and polybrene. A clinico-pathological study. J. Laryngol. Otol. 80, 651–677 (1966).
Bergstrom, L., Jenkins, P., Sando, I. & English, G. M. Hearing loss in renal disease: clinical and pathological studies. Ann. Otol. Rhinol. Laryngol. 82, 555–576 (1973).
Johnson, D. W. & Mathog, R. H. Hearing function and chronic renal failure. Ann. Otol. Rhinol. Laryngol. 85, 43–49 (1976).
Henrich, W. L., Thompson, P., Bergstrom, L. V. & Lum, G. M. Effect of dialysis on hearing acuity. Nephron 18, 348–351 (1977).
Johnson, D. W., Wathen, R. L. & Mathog, R. H. Effects of hemodialysis on hearing threshold. ORL J. Otorhinolaryngol. Relat. Spec. 38, 129–139 (1976).
Mirahmadi, M. K. & Vaziri, N. D. Hearing loss in end-stage renal disease — effect of dialysis. J. Dial. 4, 159–165 (1980).
Rizvi, S. S. & Holmes, R. A. Hearing loss from hemodialysis. Arch. Otolaryngol. 106, 751–756 (1980).
Bazzi, C., Venturini, C. T., Pagani, C., Arrigo, G. & D’Amico, G. Hearing loss in short- and long-term haemodialysed patients. Nephrol. Dial. Transpl. 10, 1865–1868 (1995).
Mancini, M. L., Dello Strologo, L., Bianchi, P. M., Tieri, L. & Rizzoni, G. Sensorineural hearing loss in patients reaching chronic renal failure in childhood. Pediatr. Nephrol. 10, 38–40 (1996).
Nikolopoulos, T. P. et al. Auditory function in young patients with chronic renal failure. Clin. Otolaryngol. Allied Sci. 22, 222–225 (1997).
Serbetcioglu, M. B., Erdogan, S. & Sifil, A. Effects of a single session of hemodialysis on hearing abilities. Acta Otolaryngol. 121, 836–838 (2001).
Peyvandi, A. & Roozbahany, N. A. Hearing loss in chronic renal failure patient undergoing hemodialysis. Indian. J. Otolaryngol. Head. Neck Surg. 65, 537–540 (2013).
Jamaldeen, J., Basheer, A., Sarma, A. C. & Kandasamy, R. Prevalence and patterns of hearing loss among chronic kidney disease patients undergoing haemodialysis. Australas. Med. J. 8, 41–46 (2015).
Reddy, E., Surya Prakash, D. & Rama Krishna, M. Proportion of hearing loss in chronic renal failure: our experience. Indian. J. Otol. 22, 4–9 (2016).
Rahman R, Akhtar N. The prevalence of hearing loss in chronic kidney disease global journal of medical research Bangladeshi patients undergoing dialysis. Glob. J. Med. Res. 16, 18–22 (2016).
Gabr, T. A., Kotait, M. A. & Okda, H. I. Audiovestibular functions in chronic kidney disease in relation to haemodialysis. J. Laryngol. Otol. 133, 592–599 (2019).
Boateng, J. O., Boafo, N., Osafo, C. & Anim-Sampong, S. Hearing impairment among chronic kidney disease patients on haemodialysis at a tertiary hospital in Ghana. Ghana. Med. J. 53, 197–203 (2019).
Fufore, M. et al. Hearing threshold of patients with chronic kidney disease undergoing haemodialysis. Int. J. Otorhinolaryngol. Head. Neck Surg. 7, 922–928 (2021).
Rahman, R., Akhtar, N., Khanam, A. & Alam, M. Prevalence and patterns of hearing loss among chronic kidney disease of various stages in Bangladeshi patients. Am. J. Med. Sci. Med. 4, 53–58 (2016).
Fufore, M. et al. Hearing loss in chronic kidney disease: an assessment of multiple aetiological parameters. Otolaryngology 10, 393 (2020).
Lara-Sanchez, H. et al. Characterization of hearing loss in adult patients with nondialysis chronic kidney disease. Otol. Neurotol. 41, e776–e782 (2020).
Liu, W. et al. The association between reduced kidney function and hearing loss: a cross-sectional study. BMC Nephrol. 21, 145 (2020).
Seo, Y. J. et al. Association of hearing impairment with chronic kidney disease: a cross-sectional study of the Korean general population. BMC Nephrol. 16, 154 (2015).
Vilayur, E. et al. The association between reduced GFR and hearing loss: a cross-sectional population-based study. Am. J. Kidney Dis. 56, 661–669 (2010).
Wu, K. L. et al. Investigation of the relationship between sensorineural hearing loss and associated comorbidities in patients with chronic kidney disease: a nationwide, population-based cohort study. PLoS ONE 15, e0238913 (2020).
Yang, D. et al. Association between kidney function and hearing impairment among middle-aged and elderly individuals: a cross-sectional population-based study. Postgrad. Med. 133, 701–706 (2021).
Jung, D. J. et al. Association between hearing impairment and albuminuria with or without diabetes mellitus. Clin. Exp. Otorhinolaryngol. 10, 221–227 (2017).
Wang, T. C. et al. Low-grade albuminuria is associated with hearing loss in non-diabetic US males: a cross-sectional analysis of 1999–2004 national health and nutrition examination survey. Medicine 99, e19284 (2020).
Bigman, G. Deficiency in vitamin D is associated with bilateral hearing impairment and bilateral sensorineural hearing loss in older adults. Nutr. Res. 105, 1–10 (2022).
Zou, J. et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiol. Neurootol. 13, 219–230 (2008).
Simsir, M. et al. Hearing impairments as an overlooked condition in kidney transplant recipients. Transpl. Int. 35, 10198 (2022).
Kim, J. H. et al. Renal syndromic hearing loss is common in childhood-onset chronic kidney disease. J. Korean Med. Sci. 35, e364 (2020).
Harer, M. W. et al. Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference. J. Perinatol. 41, 185–195 (2021).
Leow, E. H. et al. Congenital anomalies of the kidney and urinary tract (CAKUT) in critically ill infants: a multicenter cohort study. Pediatr. Nephrol. 38, 161–172 (2023).
Kashtan, C. E. & Gross, O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr. Nephrol. 36, 711–719 (2021).
Savige, J. et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J. Am. Soc. Nephrol. 24, 364–375 (2013).
Lisan, Q. et al. Prevalence of hearing loss and hearing aid use among adults in France in the CONSTANCES Study. JAMA Netw. Open. 5, e2217633–e2217633 (2022).
Gatland, D., Tucker, B., Chalstrey, S., Keene, M. & Baker, L. Hearing loss in chronic renal failure-hearing threshold changes following haemodialysis. J. R. Soc. Med. 84, 587–589 (1991).
Thodi, C., Thodis, E., Danielides, V., Pasadakis, P. & Vargemezis, V. Hearing in renal failure. Nephrol. Dial. Transpl. 21, 3023–3030 (2006).
Lasisi, A., Salako, B., Osowole, O., Osisanya, W. & Amusat, M. Effect of hemodialysis on the hearing function of patients with chronic renal failure. Afr. J. Health Sci. 13, 29–32 (2006).
Albertazzi, A., Cappelli, P., Di Marco, T., Maccarone, M. & Di Paolo, B. The natural history of uremic neuropathy. Contrib. Nephrol. 65, 130–137 (1988).
Rybak, L. P. & Ramkumar, V. Ototoxicity. Kidney Int. 72, 931–935 (2007).
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. & Egberts, A. C. Drug-related nephrotoxic and ototoxic reactions: a link through a predictive mechanistic commonality. Drug. Saf. 31, 877–884 (2008).
Taylor, R. R., Nevill, G. & Forge, A. Rapid hair cell loss: a mouse model for cochlear lesions. J. Assoc. Res. Otolaryngol. 9, 44–64 (2008).
Wushouer, H. et al. Inpatient antibacterial use trends and patterns, China, 2013–2021. Bull. World Health Organ. 101, 248–261B (2023).
Allon M. & Sexton, D. J. Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): management and prevention. UpToDate, https: //www.uptodate.com/contents/tunneled-hemodialysis-catheter-related-bloodstream-infection-crbsi-management-and-prevention (accessed 26 September 2023).
Fu, X. et al. Mechanism and prevention of ototoxicity induced by aminoglycosides. Front. Cell Neurosci. 15, 692762 (2021).
Vandebona, H. et al. Prevalence of mitochondrial 1555A–>G mutation in adults of European descent. N. Engl. J. Med. 360, 642–644 (2009).
Bitner-Glindzicz, M. et al. Prevalence of mitochondrial 1555A–>G mutation in European children. N. Engl. J. Med. 360, 640–642 (2009).
Natha, C. M., Vemulapalli, V., Fiori, M. C., Chang, C. T. & Altenberg, G. A. Connexin hemichannel inhibitors with a focus on aminoglycosides. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166115 (2021).
Chen, S. et al. The spatial distribution pattern of Connexin26 expression in supporting cells and its role in outer hair cell survival. Cell Death Dis. 9, 1180 (2018).
Zhou, X. X. et al. Reduced connexin26 in the mature cochlea increases susceptibility to noise-induced hearing loss in mice. Int. J. Mol. Sci. 17, 301 (2016).
Chan, D. K. & Chang, K. W. GJB2-associated hearing loss: systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope 124, E34–E53 (2014).
Hanner, F., Sorensen, C. M., Holstein-Rathlou, N. H. & Peti-Peterdi, J. Connexins and the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1143–R1155 (2010).
Rybak, L. P., Ramkumar, V. & Mukherjea, D. Ototoxicity of non-aminoglycoside antibiotics. Front. Neurol. 12, 652674 (2021).
Jozefowicz-Korczynska, M., Pajor, A. & Lucas Grzelczyk, W. The ototoxicity of antimalarial drugs-a state of the art review. Front. Neurol. 12, 661740 (2021).
Brock, P. R. et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J. Clin. Oncol. 30, 2408–2417 (2012).
Abou-Abdallah, M. & Lamyman, A. Exploring communication difficulties with deaf patients. Clin. Med. 21, e380–e383 (2021).
Johnson, D. W. Do antibiotic levels need to be followed in treating peritoneal dialysis-associated peritonitis? Semin. Dial. 24, 445–446 (2011).
van der Hulst, R. J. et al. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J. Otorhinolaryngol. Relat. Spec. 53, 19–22 (1991).
Li, P. K. et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit. Dial. Int. 42, 110–153 (2022).
Khan, S. A. et al. Genetics of human Bardet-Biedl syndrome, an updates. Clin. Genet. 90, 3–15 (2016).
Park, E. et al. Genotype-phenotype analysis in pediatric patients with distal renal tubular acidosis. Kidney Blood Press. Res. 43, 513–521 (2018).
Scholl, U. I. et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl Acad. Sci. USA 106, 5842–5847 (2009).
Bockenhauer, D. et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360, 1960–1970 (2009).
Abdelhadi, O., Iancu, D., Stanescu, H., Kleta, R. & Bockenhauer, D. EAST syndrome: clinical, pathophysiological, and genetic aspects of mutations in KCNJ10. Rare Dis. 4, e1195043 (2016).
Author information
Authors and Affiliations
Contributions
All authors researched data for the article, contributed substantially to discussion of the content and wrote the article. N.D.R. and M.T. reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Nephrology thanks Judy Savige and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Greenberg, D., Rosenblum, N.D. & Tonelli, M. The multifaceted links between hearing loss and chronic kidney disease. Nat Rev Nephrol 20, 295–312 (2024). https://doi.org/10.1038/s41581-024-00808-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-024-00808-2